These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 33026

  • 21. Metabolic deacetylation: in vitro and in vivo studies in man, rat, dog and rhesus monkey with isomeric tetrahydroisoquinolyl derivatives of 3,4-dimethylbenzyl acetate.
    Allen JG, Burden T, Haigh JL, Parkes MW, Fothergill GA.
    Arzneimittelforschung; 1976 Apr; 26(4):568-72. PubMed ID: 8060
    [Abstract] [Full Text] [Related]

  • 22. Metabolism of methylphenidate in dog and rat.
    Egger H, Bartlett F, Dreyfuss R, Karliner J.
    Drug Metab Dispos; 1981 Apr; 9(5):415-23. PubMed ID: 6117439
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics and metabolism of cefazedone in Wistar rat, beagle dog and rhesus monkey.
    Sailer H, Diekmann HW, Faro HP, Garbe A.
    Arzneimittelforschung; 1979 Apr; 29(2a):404-11. PubMed ID: 114189
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
    Vincent SH, Painter SK, Luffer-Atlas D, Karanam BV, McGowan E, Cioffe C, Doss G, Chiu SH.
    Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401
    [Abstract] [Full Text] [Related]

  • 28. Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man.
    Brodie RR, Chasseaud LF, Elson FF, Franklin ER, Taylor T.
    Arzneimittelforschung; 1976 Aug; 26(5):896-901. PubMed ID: 989365
    [Abstract] [Full Text] [Related]

  • 29. Metabolism and biliary excretion of 2,4,5,2',4',5'-hexachlorobiphenyl in the rhesus monkey (Macaca mulatta).
    Norback DH, Mack E, Reddy G, Britt J, Hsia MT.
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):71-85. PubMed ID: 6794118
    [Abstract] [Full Text] [Related]

  • 30. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN, Mannens G, Annaert P, Hendrickx J, Goris I, Bockx M, Janssen CG, Kao M, Kelley MF, Meuldermans W.
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [Abstract] [Full Text] [Related]

  • 31. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Yoshida K, Itogawa A, Tagawa M, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [Abstract] [Full Text] [Related]

  • 32. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ, Duncan AE, Delauna FA, Hucker HB, Gruber VF, Vandenheuvel WJ.
    Drug Metab Dispos; 1975 Oct; 3(5):361-70. PubMed ID: 241617
    [Abstract] [Full Text] [Related]

  • 33. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.
    Malspeis L, Bathala MS, Ludden TM, Bhat HB, Frank SG, Sokoloski TD, Morrison BE, Reuning RH.
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832
    [Abstract] [Full Text] [Related]

  • 34. Absorption and disposition of [14C]-molsidomine in laboratory animals.
    Fromson JM, Illing HP, Ings RM, Johnson KI, Johnson P, Ostrowski J, Schraven E, Steward A.
    Arzneimittelforschung; 1981 Sep; 31(2):337-45. PubMed ID: 6894378
    [Abstract] [Full Text] [Related]

  • 35. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U, Breuer O, Swedmark S, Hoogstraate J.
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [Abstract] [Full Text] [Related]

  • 36. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
    Lan SJ, El-Hawey AM, Dean AV, Schreiber EC.
    Drug Metab Dispos; 1975 May; 3(3):171-9. PubMed ID: 238816
    [Abstract] [Full Text] [Related]

  • 37. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)].
    Niebch G, Obermeier K, Vergin H, Thiemer K.
    Arzneimittelforschung; 1977 May; 27(12):37-45. PubMed ID: 576829
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of the pivaloyloxyethyl (POE) ester of methyldopa, a new prodrug of methyldopa.
    Dobrinska MR, Kukovetz W, Beubler E, Leidy HL, Gomez HJ, Demetriades J, Bolognese JA.
    J Pharmacokinet Biopharm; 1982 Dec; 10(6):587-600. PubMed ID: 7182456
    [Abstract] [Full Text] [Related]

  • 39. The disposition and metabolism of 5-(4,5-dihydro-2-phenylbenz[e]indol-3-yl)salicylic acid (fendosal) in the rat, mouse, rabbit, do, rhesus monkey, and man.
    Warrander A, Metcalf R, Fromson JM.
    Drug Metab Dispos; 1981 Dec; 9(2):161-7. PubMed ID: 6113117
    [Abstract] [Full Text] [Related]

  • 40. Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
    Cooper AE, Gray AJ, Collington J, Seddon H, Beattie I, Logan CJ.
    Drug Metab Dispos; 1996 Oct; 24(10):1071-80. PubMed ID: 8894507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.